Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 1998 Jul;16(7):2417-25.
doi: 10.1200/JCO.1998.16.7.2417.

Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk

T S Frank  1 , S A Manley, O I Olopade, S Cummings, J E Garber, B Bernhardt, K Antman, D Russo, M E Wood, L Mullineau, C Isaacs, B Peshkin, S Buys, V Venne, P T Rowley, S Loader, K Offit, M Robson, H Hampel, D Brener, E P Winer, S Clark, B Weber, L C Strong, A Thomas, et al.
Affiliations
Multicenter Study

Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk

T S Frank et al. J Clin Oncol. 1998 Jul.

Abstract

Purpose: Previous studies of mutations in BRCA1 or BRCA2 have used detection methods that may underestimate the actual frequency of mutations and have analyzed women using heterogeneous criteria for risk of hereditary cancer.

Patients and methods: A total of 238 women with breast cancer before age 50 or ovarian cancer at any age and at least one first- or second-degree relative with either diagnosis underwent sequence analysis of BRCA1 followed by analysis of BRCA2 (except for 27 women who declined analysis of BRCA2 after a deleterious mutation was discovered in BRCA1). Results were correlated with personal and family history of malignancy.

Results: Deleterious mutations were identified in 94 (39%) women, including 59 of 117 (50%) from families with ovarian cancer and 35 of 121 (29%) from families without ovarian cancer. Mutations were identified in 14 of 70 (20%) women with just one other relative who developed breast cancer before age 50. In women with breast cancer, mutations in BRCA1 and BRCA2 were associated with a 10-fold increased risk of subsequent ovarian carcinoma (P = .005).

Conclusion: Because mutations in BRCA1 and BRCA2 in women with breast cancer are associated with an increased risk of ovarian cancer, analysis of these genes should be considered for women diagnosed with breast cancer who have a high probability of carrying a mutation according to the statistical model developed with these data.

PubMed Disclaimer

Publication types